United States Healthcare Equipment & Supplies

Pulmonx Corp (LUNG)

Track

Over the past 90 days, Pulmonx Corp insiders have executed 15 sell transactions totaling approximately $144,030 in net value. Key executives, including the CEO, General Counsel, and Chief Commercial Officer, were involved in these sales. No insider purchases were recorded during this period, which follows the company's most recent earnings report in April 2026.
Ticker: LUNG Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Pulmonx Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 2 Jun 2026
Value US$4,396,767.72 | Price 298.94 | Shares 61,400 (+25.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-02 S Sale
3.5
French Glendon E. III

President and CEO

Executive Director
61,400 +25.3%
298.94
US$4,396,768 		61,400 +25.3% 298.94 US$4,396,768
2026-06-03 2026-06-01 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
25,795 -19.6%
206.66
US$1,682,177 		25,795 -19.6% 206.66 US$1,682,177
2026-06-03 2026-06-01 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
48,879 -11.2%
498.66
US$4,486,045 		48,879 -11.2% 498.66 US$4,486,045
2026-06-03 2026-06-01 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
2,264 -0.6%
1.54
US$3,487 		2,264 -0.6% 1.54 US$3,487
2026-06-03 2026-06-01 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
3,876 -1.0%
1.54
US$5,969 		3,876 -1.0% 1.54 US$5,969
2026-06-03 2026-06-01 S Sale
3.5
French Glendon E. III

President and CEO

Executive Director
38,467 -3.1%
1.54
US$59,239 		38,467 -3.1% 1.54 US$59,239
2026-06-03 2026-06-01 S Sale
3.5
French Glendon E. III

President and CEO

Executive Director
4,171 -0.3%
1.54
US$6,423 		4,171 -0.3% 1.54 US$6,423
2026-06-03 2026-06-01 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
2,254 -0.5%
1.54
US$3,471 		2,254 -0.5% 1.54 US$3,471
2026-06-03 2026-06-01 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
2,434 -0.5%
1.54
US$3,748 		2,434 -0.5% 1.54 US$3,748
2026-06-03 2026-06-01 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
1,557 -0.3%
1.54
US$2,398 		1,557 -0.3% 1.54 US$2,398
2026-06-03 2026-06-01 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
1,778 -0.4%
1.54
US$2,738 		1,778 -0.4% 1.54 US$2,738
2026-06-03 2026-06-01 S Sale
2.4
Radhakrishnan Srikanth

Chief Science &Techn. Officer

Officer
5,969 -1.8%
1.54
US$9,192 		5,969 -1.8% 1.54 US$9,192
2026-06-03 2026-06-01 S Sale
2.4
Radhakrishnan Srikanth

Chief Science &Techn. Officer

Officer
3,684 -1.1%
1.54
US$5,673 		3,684 -1.1% 1.54 US$5,673
2026-06-03 2026-06-01 S Sale
2.4
Radhakrishnan Srikanth

Chief Science &Techn. Officer

Officer
2,153 -0.6%
1.54
US$3,316 		2,153 -0.6% 1.54 US$3,316
2026-06-03 2026-06-01 S Sale
2.4
Radhakrishnan Srikanth

Chief Science &Techn. Officer

Officer
2,691 -0.8%
1.54
US$4,144 		2,691 -0.8% 1.54 US$4,144
2026-03-04 2026-03-02 S Sale
2.4
Radhakrishnan Srikanth

Chief Science &Techn. Officer

Officer
4,198 -2.4%
1.43
US$6,003 		4,198 -2.4% 1.43 US$6,003
2026-03-04 2026-03-02 S Sale
2.4
Radhakrishnan Srikanth

Chief Science &Techn. Officer

Officer
2,461 -1.4%
1.43
US$3,519 		2,461 -1.4% 1.43 US$3,519
2026-03-04 2026-03-02 S Sale
2.4
Radhakrishnan Srikanth

Chief Science &Techn. Officer

Officer
3,068 -1.7%
1.43
US$4,387 		3,068 -1.7% 1.43 US$4,387
2026-03-04 2026-03-02 S Sale
2.4
Radhakrishnan Srikanth

Chief Science &Techn. Officer

Officer
756 -0.4%
1.43
US$1,081 		756 -0.4% 1.43 US$1,081
2026-03-04 2026-03-02 S Sale
3.5
French Glendon E. III

President and CEO

Executive Director
58,368 -4.0%
1.43
US$83,466 		58,368 -4.0% 1.43 US$83,466
2026-03-04 2026-03-02 S Sale
3.5
French Glendon E. III

President and CEO

Executive Director
6,737 -0.5%
1.43
US$9,634 		6,737 -0.5% 1.43 US$9,634
2026-03-04 2026-03-02 S Sale
3.5
French Glendon E. III

President and CEO

Executive Director
2,708 -0.2%
1.43
US$3,872 		2,708 -0.2% 1.43 US$3,872
2026-03-04 2026-03-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
4,051 -1.7%
1.43
US$5,793 		4,051 -1.7% 1.43 US$5,793
2026-03-04 2026-03-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
2,590 -1.0%
1.43
US$3,704 		2,590 -1.0% 1.43 US$3,704
2026-03-04 2026-03-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
4,433 -1.8%
1.43
US$6,339 		4,433 -1.8% 1.43 US$6,339
2026-03-04 2026-03-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
1,163 -0.5%
1.43
US$1,663 		1,163 -0.5% 1.43 US$1,663
2026-03-04 2026-03-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
2,911 -0.8%
1.43
US$4,163 		2,911 -0.8% 1.43 US$4,163
2026-03-04 2026-03-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
1,861 -0.5%
1.43
US$2,661 		1,861 -0.5% 1.43 US$2,661
2026-03-04 2026-03-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
2,125 -0.6%
1.43
US$3,039 		2,125 -0.6% 1.43 US$3,039
2026-03-04 2026-03-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
835 -0.2%
1.43
US$1,194 		835 -0.2% 1.43 US$1,194
2026-01-22 2026-01-22 PrS Proposed sale
2.7
STEVEN WILLIAMSON

Officer; Director

Executive Director
48,892
1.95
US$95,339 		48,892 1.95 US$95,339
2026-01-15 2026-01-15 PrS Proposed sale
2.7
STEVEN WILLIAMSON

Officer; Director

Executive Director
15,892
1.95
US$31,039 		15,892 1.95 US$31,039
2026-01-14 2026-01-14 PrS Proposed sale
2.7
STEVEN WILLIAMSON

Officer; Director

Executive Director
31,082
2.00
US$62,074 		31,082 2.00 US$62,074
2025-12-09 2025-12-08 PlS Planned sale
0.6
Florin Daniel P
Non-Executive Director
23,321 -19.9%
1.99
US$46,409 		23,321 -19.9% 1.99 US$46,409
2025-12-08 2025-12-08 PrS Proposed sale
0.6
DANIEL P FLORIN

Director

Non-Executive Director
23,321
1.99
US$46,385 		23,321 1.99 US$46,385
2025-12-03 2025-12-01 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
2,379 -0.6%
1.57
US$3,735 		2,379 -0.6% 1.57 US$3,735
2025-12-03 2025-12-01 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
1,522 -0.4%
1.57
US$2,390 		1,522 -0.4% 1.57 US$2,390
2025-12-03 2025-12-01 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
1,738 -0.5%
1.57
US$2,729 		1,738 -0.5% 1.57 US$2,729
2025-12-03 2025-12-01 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
683 -0.2%
1.57
US$1,072 		683 -0.2% 1.57 US$1,072
2025-12-03 2025-12-01 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
3,401 -1.3%
1.57
US$5,340 		3,401 -1.3% 1.57 US$5,340
2025-12-03 2025-12-01 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
2,176 -0.8%
1.57
US$3,416 		2,176 -0.8% 1.57 US$3,416
2025-12-03 2025-12-01 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
3,725 -1.4%
1.57
US$5,848 		3,725 -1.4% 1.57 US$5,848
2025-12-03 2025-12-01 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
976 -0.4%
1.57
US$1,532 		976 -0.4% 1.57 US$1,532
2025-12-03 2025-12-01 S Sale
3.5
French Glendon E. III

President and CEO

Executive Director
6,281 -2.2%
1.57
US$9,861 		6,281 -2.2% 1.57 US$9,861
2025-12-03 2025-12-01 S Sale
3.5
French Glendon E. III

President and CEO

Executive Director
2,524 -0.9%
1.57
US$3,963 		2,524 -0.9% 1.57 US$3,963
2025-09-03 2025-09-02 S Sale
3.3
Joshi Mehul

Chief Financial Officer & PAO

Officer
3,665 -1.7%
1.60
US$5,864 		3,665 -1.7% 1.60 US$5,864
2025-09-03 2025-09-02 PlS Planned sale
3.3
Joshi Mehul

Chief Financial Officer & PAO

Officer
4,271 -2.0%
1.60
US$6,834 		4,271 -2.0% 1.60 US$6,834
2025-09-03 2025-09-02 S Sale
2.7
Williamson Steven S.

PRESIDENT AND CEO

Executive Director
4,530 -1.2%
1.60
US$7,248 		4,530 -1.2% 1.60 US$7,248
2025-09-03 2025-09-02 PlS Planned sale
2.7
Williamson Steven S.

PRESIDENT AND CEO

Executive Director
5,118 -1.4%
1.60
US$8,189 		5,118 -1.4% 1.60 US$8,189
2025-09-03 2025-09-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
2,462 -0.6%
1.60
US$3,939 		2,462 -0.6% 1.60 US$3,939
2025-09-03 2025-09-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
1,575 -0.4%
1.60
US$2,520 		1,575 -0.4% 1.60 US$2,520
2025-09-03 2025-09-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
1,799 -0.5%
1.60
US$2,878 		1,799 -0.5% 1.60 US$2,878
2025-09-03 2025-09-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
707 -0.2%
1.60
US$1,131 		707 -0.2% 1.60 US$1,131
2025-09-03 2025-09-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
3,231 -1.2%
1.60
US$5,170 		3,231 -1.2% 1.60 US$5,170
2025-09-03 2025-09-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
2,068 -0.8%
1.60
US$3,309 		2,068 -0.8% 1.60 US$3,309
2025-09-03 2025-09-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
3,541 -1.3%
1.60
US$5,666 		3,541 -1.3% 1.60 US$5,666
2025-09-03 2025-09-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
929 -0.3%
1.60
US$1,486 		929 -0.3% 1.60 US$1,486
2025-06-13 2025-06-13 PrS Proposed sale
2.3
Ferrari Richard

Director

Non-Executive Director
5,438
3.01
US$16,368 		5,438 3.01 US$16,368
2025-06-13 2025-06-12 S Sale
2.3
Ferrari Richard
Non-Executive Director
8,000 -8.4%
3.16
US$25,280 		8,000 -8.4% 3.16 US$25,280
2025-06-12 2025-06-12 PrS Proposed sale
2.3
RICH FERRARI

Director

Non-Executive Director
8,000
3.16
US$25,307 		8,000 3.16 US$25,307
2025-06-05 2025-06-05 B Purchase
0.6
Florin Daniel P
Non-Executive Director
23,321 +24.8%
3.06
US$71,362 		23,321 +24.8% 3.06 US$71,362
2025-06-04 2025-06-02 S Sale
3.3
Joshi Mehul

Chief Financial Officer & PAO

Officer
3,721 -1.7%
3.13
US$11,647 		3,721 -1.7% 3.13 US$11,647
2025-06-04 2025-06-02 S Sale
3.3
Joshi Mehul

Chief Financial Officer & PAO

Officer
4,340 -2.0%
3.13
US$13,584 		4,340 -2.0% 3.13 US$13,584
2025-06-04 2025-06-02 S Sale
2.7
Williamson Steven S.

PRESIDENT AND CEO

Executive Director
4,661 -1.3%
3.13
US$14,589 		4,661 -1.3% 3.13 US$14,589
2025-06-04 2025-06-02 S Sale
2.7
Williamson Steven S.

PRESIDENT AND CEO

Executive Director
5,262 -1.4%
3.13
US$16,470 		5,262 -1.4% 3.13 US$16,470
2025-06-04 2025-06-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
3,283 -1.2%
3.13
US$10,276 		3,283 -1.2% 3.13 US$10,276
2025-06-04 2025-06-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
2,099 -0.8%
3.13
US$6,570 		2,099 -0.8% 3.13 US$6,570
2025-06-04 2025-06-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
3,597 -1.3%
3.13
US$11,259 		3,597 -1.3% 3.13 US$11,259
2025-06-04 2025-06-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
943 -0.3%
3.13
US$2,952 		943 -0.3% 3.13 US$2,952
2025-06-04 2025-06-02 S Sale
3.6
Lehman David Aaron

GENERAL COUNSEL

Officer
535 -0.2%
3.14
US$1,680 		535 -0.2% 3.14 US$1,680
2025-06-04 2025-06-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
2,463 -0.6%
3.13
US$7,709 		2,463 -0.6% 3.13 US$7,709
2025-06-04 2025-06-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
1,576 -0.4%
3.13
US$4,933 		1,576 -0.4% 3.13 US$4,933
2025-06-04 2025-06-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
1,799 -0.5%
3.13
US$5,631 		1,799 -0.5% 3.13 US$5,631
2025-06-04 2025-06-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
708 -0.2%
3.13
US$2,216 		708 -0.2% 3.13 US$2,216
2025-06-04 2025-06-02 S Sale
3.5
Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Officer
401 -0.1%
3.14
US$1,259 		401 -0.1% 3.14 US$1,259
Explore more

More insider trading research around Pulmonx Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America